Ignite Creation Date:
2024-05-05 @ 4:56 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00345345
Status:
COMPLETED
Last Update Posted:
2022-05-03
First Post:
2006-06-27
Brief Title:
Alemtuzumab Campath to Treat T-Large Granular Lymphocyte Leukemia
Sponsor:
National Heart Lung and Blood Institute NHLBI
Organization:
National Institutes of Health Clinical Center CC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-10-17
Start Date Type:
ACTUAL
Primary Completion Date:
2017-08-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-10-27
Completion Date Type:
ACTUAL
First Submit Date:
2006-06-27
First Submit QC Date:
June 27 2006
Study First Post Date:
2006-06-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2019-05-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-05
Last Update Post Date:
2022-05-03
Last Update Post Date Type:
ACTUAL